AnyGenes Biotechnology Company Specializing in Cell Signaling Pathway Analysis and RNA Expression
About the AnyGenes biotechnology company
AnyGenes is a biotechnology company founded in 2007 by scientists with more than 20 years of experience in molecular and cellular biology.
Since its creation, the AnyGenes biotechnology company has focused on developing molecular tools that help researchers explore cell signaling pathways, RNA expression, and biomarker discovery. Understanding how signaling networks regulate gene expression is essential for studying disease mechanisms and identifying new therapeutic targets.
Located in Paris, France, AnyGenes collaborates with academic laboratories, biotechnology companies, and pharmaceutical research teams worldwide
Discover AnyGenes Technologies
To better understand how the AnyGenes biotechnology company develops innovative tools for cell signaling pathway analysis and biomarker research, watch our short introduction video.
qPCR arrays for cell signaling pathway analysis
One of the core activities of the AnyGenes biotechnology company is the development of qPCR arrays dedicated to cell signaling pathway analysis.
AnyGenes has built a large portfolio of more than 500 ready-to-use signaling pathway panels, allowing scientists to analyze gene expression signatures associated with key biological processes such as:
inflammation
apoptosis
oxidative stress
immune response
metabolism
cancer signaling pathways
These pathway-focused qPCR arrays enable researchers to rapidly identify dysregulated pathways and potential biomarkers in experimental models and clinical research.
Molecular tools for biomarker research
Beyond signaling pathway panels, the AnyGenes develops molecular tools designed to support advanced biological research.
These solutions allow researchers to perform reliable gene expression analysis even with limited or challenging biological samples.
Customized molecular services
In addition to its product portfolio, AnyGenes offers custom molecular services based on its proprietary platforms.
These services support research projects such as:
drug development programs
biomarker validation studies
mechanism of action analysis
signaling pathway profiling
By combining pathway-focused gene expression panels with strong scientific expertise, the AnyGenes biotechnology company helps researchers better understand molecular mechanisms involved in human diseases.
Supporting scientific research worldwide
For more than 15 years, technologies developed by the AnyGenes biotechnology company have been used in a wide range of biomedical research fields, including:
cancer biology
immunology
metabolic disorders
neurodegenerative diseases
precision medicine
Numerous scientific publications have used AnyGenes products and services to investigate molecular pathways involved in disease progression and therapeutic responses.
What does the AnyGenes biotechnology company specialize in?
The AnyGenes biotechnology company specializes in the development of pathway-focused qPCR arrays and molecular tools used to analyze cell signaling pathways, gene expression and biomarkers involved in human diseases.
What technologies does AnyGenes develop?
AnyGenes develops pathway-focused qPCR arrays and molecular assays designed to study gene expression and signaling pathways involved in cancer, inflammation, metabolism and other biological processes.
Who uses AnyGenes technologies?
AnyGenes technologies are used by academic laboratories, biotechnology companies and pharmaceutical research teams worldwide for gene expression analysis and pathway-based biomarker research.
How can researchers access AnyGenes products or services?
Researchers can contact the AnyGenes team directly to learn more about available qPCR arrays, molecular tools and customized services for pathway analysis and biomarker discovery.